Tabrizchi R, King K A, Pang C C
Department of Pharmacology and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
Pharmacology. 1988;37(6):385-93. doi: 10.1159/000138493.
The purpose of this study was to examine the conditions whereby beta-blockers cause a pressor response in conscious, unrestrained rats: (1) whether beta-blockers cause a pressor response in rats subjected to, or not subjected to, nonselective alpha-blockade with phentolamine; (2) whether the pressor response to beta-blockers is due to the blockade of vasodilator beta 2-adrenoceptors, and (3) whether it is due to an acute increase in the release of adrenaline (A) and noradrenaline (NA). In the first series of experiments cumulative dose-response curves for propranolol, atenolol and ICI 118,551, nonselective beta-, beta 1- and beta 2-selective antagonists, respectively, were constructed in rats subjected to a continuous intravenous infusion of phentolamine. The administration of each of the beta-antagonists caused a significant dose-dependent increase in mean arterial pressure (MAP). The ED50 values for the increase in MAP were found to be 3.6 +/- 0.8, 10 +/- 2.6 and 4.6 +/- 0.8 micrograms/kg for propranolol, atenolol and ICI 118,551, respectively. In the second series of experiments, a single bolus injection of a selective or nonselective beta-antagonist or saline vehicle was given to rats subjected to a continuous intravenous infusion of phentolamine. Plasma levels of A and NA were determined in the control condition, during the infusion of phentolamine and again after the injection of a beta-antagonist. The infusion of phentolamine significantly decreased MAP and increased plasma levels of A and NA.(ABSTRACT TRUNCATED AT 250 WORDS)
本研究的目的是考察β受体阻滞剂在清醒、未束缚大鼠中引起升压反应的条件:(1)β受体阻滞剂在接受或未接受酚妥拉明非选择性α受体阻滞的大鼠中是否引起升压反应;(2)对β受体阻滞剂的升压反应是否由于血管舒张性β2肾上腺素能受体的阻滞,以及(3)是否由于肾上腺素(A)和去甲肾上腺素(NA)释放的急性增加。在第一系列实验中,分别在持续静脉输注酚妥拉明的大鼠中构建了普萘洛尔、阿替洛尔和ICI 118,551(分别为非选择性β、β1和β2选择性拮抗剂)的累积剂量-反应曲线。给予每种β拮抗剂均引起平均动脉压(MAP)显著的剂量依赖性升高。发现普萘洛尔、阿替洛尔和ICI 118,551使MAP升高的ED50值分别为3.6±0.8、10±2.6和4.6±0.8微克/千克。在第二系列实验中,对持续静脉输注酚妥拉明的大鼠单次推注选择性或非选择性β拮抗剂或生理盐水载体。在对照条件下、酚妥拉明输注期间以及注射β拮抗剂后再次测定血浆A和NA水平。酚妥拉明输注显著降低MAP并升高血浆A和NA水平。(摘要截断于250字)